SCHEMBL22728372

SCHEMBL22728372

C=C(C)c1ccc(C)cc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.44
PDE3A Q14432 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.41
CES2 O00748 1/20 0.39
TP53 P04637 2/20 0.38
MAPT P10636 2/20 0.38
RAB9A P51151 2/20 0.38
SYK P43405 1/20 0.36
ALDH1A1 P00352 1/20 0.36
ALOX12 P18054 1/20 0.36
AR P10275 6/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.33
P2RX1 P51575 1/20 0.33
TMPRSS4 Q9NRS4 1/20 0.33
KIF11 P52732 1/20 0.33
KCNK3 O14649 1/20 0.32
KCNK9 Q9NPC2 1/20 0.32
AKR1C3 P42330 1/20 0.32
AKR1C2 P52895 1/20 0.32
FFAR4 Q5NUL3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26019654 0.81 SMN1; SMN2 (0.39) PDE3BPDE3ASMN1; SMN2CES2TP53
SCHEMBL7787350 0.81 CES2 (0.47) SMN1; SMN2CES2TP53MAPTRAB9A
SCHEMBL26854405 0.81 PDE3B (0.44) PDE3BPDE3ACES2ARKIF11
SCHEMBL38659817 0.79 GAA (0.52) PDE3BPDE3ACES2MAPTALDH1A1
SCHEMBL107636 0.78 CSNK2A1 (0.52) SMN1; SMN2CES2TP53MAPTRAB9A
SCHEMBL28471721 0.78 CES2 (0.48) SMN1; SMN2CES2TP53MAPTRAB9A
SCHEMBL3910361 0.77 KIF11 (0.42) PDE3BPDE3ACES2ARKIF11
SCHEMBL108796 0.76 SMN1; SMN2 (0.47) SMN1; SMN2CES2TP53MAPTRAB9A
SCHEMBL4620600 0.76 CES2 (0.46) SMN1; SMN2CES2TP53MAPTRAB9A
SCHEMBL1820394 0.74 CSNK2A1 (0.40) SMN1; SMN2TP53MAPTALDH1A1ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020243027-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE SAGE THERAPEUTICS, INC. (US) 2020-12-03 WO disclosed